Patents by Inventor Simin Xu

Simin Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV GENOTYPE 4D REPLICONS
    Publication number: 20150072418
    Abstract: Replicons of genotype 4d hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 4d replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: August 14, 2014
    Publication date: March 12, 2015
    Inventors: HADAS DVORY-SOBOL, CHRISTY HEBNER, HONGMEI MO, SIMIN XU
  • HCV genotype 4 replicons
    Patent number: 8889849
    Abstract: Replicons of genotype 4 hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 4 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: November 18, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Betty Peng
  • HCV genotype 3 replicons
    Patent number: 8889848
    Abstract: Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: November 18, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Mei Yu, Amoreena Corsa
  • HCV GENOTYPE 4 REPLICONS
    Publication number: 20130052634
    Abstract: Replicons of genotype 4 hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 4 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: July 5, 2012
    Publication date: February 28, 2013
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Betty Peng
  • HCV GENOTYPE 3 REPLICONS
    Publication number: 20130052633
    Abstract: Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: July 5, 2012
    Publication date: February 28, 2013
    Applicant: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Mei Yu, Amoreena Corsa